Conjugation Strategies Across Emerging Therapeutic Modalities

In this Fierce webinar, ChemPartner expert Philip Clarke, PhD, will highlight advances in next‑generation conjugation across emerging modalities beyond traditional ADCs. The presentation will cover innovations in peptide conjugates, oligonucleotide (ON) targeting, PROTACs and more. | The presentation will cover innovations in peptide conjugates, oligonucleotide (ON) targeting, PROTACs and more.

Raccontata dafiercebiotech.com